Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Medtronic launches Discyphor direct catheter system

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

UK Medical Device Testing Jumps 17%,...

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse...

Medtronic announced that it has secured FDA premarket approval...

Medica Axon Diagnostics Merger Expands UK...

Teleradiology provider Medica Group has agreed to integrate Axon...
Medtronic, Inc. announced the U.S. launch of the Discyphor Direct™ Catheter System, the second-generation catheter system used by physicians to obtain additional information to diagnose discogenic low back pain.

The Discyphor Direct Catheter System provides additional information to help identify which disc is causing a patient’s pain.  More than 100,000 patients annually undergo spinal surgery for discogenic low back pain in the United States1, but patient satisfaction from such surgeries is mixed.

Robert White, president of Kyphon and Interspinous Process Decompression Devices for the Spinal and Biologics at Medtronic said, With the Discyphor Direct Catheter System, we are empowering physicians to  independently assess discs to determine the source of a patient’s back pain while delivering many enhancements over our first-generation product. Both patients and physicians will benefit from this new system because of its improved ease of use and a needle that is designed with an atraumatic or blunt tip.

With the Discyphor Direct Catheter System, physicians use Medtronic’s innovative Functional Anaesthetic Discography™ (F.A.D. ™) Procedure that identifies a patient’s discogenic pain by anesthetizing each suspect disc individually.  This procedure differs from typical means of diagnosis such as imaging studies or provocative discography, which generates pain in an attempt to locate the suspected disc.  The F.A.D. Procedure was introduced two years ago and has been used on more than 3,000 patients.

Latest stories

Related stories

UK Medical Device Testing Jumps 17%, AI and Neurotech Lead

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse Bone Graft in TLIF

Medtronic announced that it has secured FDA premarket approval...

Medica Axon Diagnostics Merger Expands UK Clinical Reporting

Teleradiology provider Medica Group has agreed to integrate Axon...

Sutter Health Integrates AI Decision Support in Epic EHR

Sutter Health is integrating artificial intelligence-powered decision support technology...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »